A New Recombinant Cell Bioassay for Ultrasensitive Determination of Serum Estrogenic Bioactivity in Children
Françoise Paris,
Nadège Servant,
Béatrice Térouanne,
Patrick Balaguer,
Jean Claude Nicolas and
Charles Sultan
Unité INSERM 439 (F.P., N.S., B.T., P.B., J.C.N., C.S.), Pathologie Moléculaire des Récepteurs Nucléaires, Montpellier 34090, France; Service dHormonologie du Développement et de la Reproduction (F.P., C.S.), Hôpital Lapeyronie, 34295 Montpellier, France; and Unité dEndocrinologie Pédiatrique (F.P., C.S.), Service de Pédiatrie 1, Hôpital Arnaud de Villeneuve, 34295 Montpellier, France
Address all correspondence and requests for reprints to: Pr. Charles Sultan, INSERM U.439, Pathologie Moléculaire des Récepteurs Nucléaires, 60 rue de Navacelles, 34090 Montpellier, France. E-mail: chsultan{at}u439.montp.inserm.fr
Abstract
The evaluation of estrogenic status is necessary for many physiologicaland pathological conditions in pediatric as well as adult endocrinology.Because current immunoassays exclusively measure E2andwith a sensitivity that is insufficient for prepubertal childrenwedeveloped a new recombinant cell bioassay for ultrasensitivedetermination of serum estrogenic bioactivity. This assay isbased on human uterine cervix carcinoma cells, HeLa cells, thatdo not naturally express E2 receptor. These cells were transfectedwith plasmids encoding the human ER or ß, along withan estrogen-responsive promoter fused to the luciferase gene,and called HELN and HELNß for HeLa estrogen-responsiveelement luciferase neomycin and ß. HELN and HELNßare able to respond to estrogens and various compounds havingestrogenic activity but, because of the importance of ER inthe reproductive function, we chose to work with the HELN cellline. The luciferase activity we obtained was compared withan E2 standard curve specific for each serum sample and establishedwith stripped serum. The estrogenic bioactivity was expressedin picograms of E2 equivalents, and the detection limit was< 1 pg·ml-1 E2 equivalents. The intra and interassayerror was lower than 10% and 20%, respectively. We measuredestrogenic bioactivity in 18 normal prepubertal boys (age =9.7 ± 2.4 yr), 18 normal prepubertal girls (age = 9.2± 1.7 yr) and 18 normal pubertal girls (age = 13.6 ±1.8 yr). The estrogenic bioactivity in the prepubertal girlswas significantly higher than in the boys, i.e. 3.53 ±2.23 pg·ml-1vs. 1.44 ± 0.87 pg·ml-1 (P< 0.01). A significant difference was found between the pre-and pubertal girls, i.e. 3.53 ± 2.23 pg·ml-1vs.26.77 ± 18.32 pg·ml-1 (P < 0.01). This ultrasensitivebioassay measures total estrogenic bioactivity of serum withvery high sensitivity. It has numerous potential applicationsin pediatric and adult endocrinology. In addition, this assaymay help to evaluate excess estrogenic activity related to aromataseoverexpression or contamination by environmental chemicals.
This article has been cited by other articles:
F. Courant, L. Aksglaede, J.-P. Antignac, F. Monteau, K. Sorensen, A.-M. Andersson, N. E. Skakkebaek, A. Juul, and B. L. Bizec Assessment of Circulating Sex Steroid Levels in Prepubertal and Pubertal Boys and Girls by a Novel Ultrasensitive Gas Chromatography-Tandem Mass Spectrometry Method
J. Clin. Endocrinol. Metab.,
January 1, 2010;
95(1):
82 - 92.
[Abstract][Full Text][PDF]
C. Ankarberg-Lindgren, E. Norjavaara, M. M. Kushnir, W. L. Roberts, A. L. Rockwood, J. Bergquist, A. M. Bunker, and A. W. Meikle Are Estradiol Results Determined by the Tandem Mass Spectrometry Assay Clinically Useful for Children?
Am J Clin Pathol,
May 1, 2009;
131(5):
746 - 750.
[Full Text][PDF]
C. Ankarberg-Lindgren and E. Norjavaara A purification step prior to commercial sensitive immunoassay is necessary to achieve clinical usefulness when quantifying serum 17 -estradiol in prepubertal children
Eur. J. Endocrinol.,
January 1, 2008;
158(1):
117 - 124.
[Abstract][Full Text][PDF]
P. Roy, M. Alevizaki, and I. Huhtaniemi In vitro bioassays for androgens and their diagnostic applications
Hum. Reprod. Update,
January 1, 2008;
14(1):
73 - 82.
[Abstract][Full Text][PDF]
L. Aksglaede, A. Juul, H. Leffers, N. E. Skakkebaek, and A.-M. Andersson The sensitivity of the child to sex steroids: possible impact of exogenous estrogens
Hum. Reprod. Update,
July 1, 2006;
12(4):
341 - 349.
[Abstract][Full Text][PDF]
S. Wang, F. Paris, C. S. Sultan, R. X.-D. Song, L. M. Demers, B. Sundaram, J. Settlage, S. Ohorodnik, and R. J. Santen Recombinant Cell Ultrasensitive Bioassay for Measurement of Estrogens in Postmenopausal Women
J. Clin. Endocrinol. Metab.,
March 1, 2005;
90(3):
1407 - 1413.
[Abstract][Full Text][PDF]
E. Sonneveld, H. J. Jansen, J. A. C. Riteco, A. Brouwer, and B. van der Burg Development of Androgen- and Estrogen-Responsive Bioassays, Members of a Panel of Human Cell Line-Based Highly Selective Steroid-Responsive Bioassays
Toxicol. Sci.,
January 1, 2005;
83(1):
136 - 148.
[Abstract][Full Text][PDF]
T. Raivio, L. Dunkel, S. Wickman, and O. A. Janne Serum Androgen Bioactivity in Adolescence: A Longitudinal Study of Boys with Constitutional Delay of Puberty
J. Clin. Endocrinol. Metab.,
March 1, 2004;
89(3):
1188 - 1192.
[Abstract][Full Text][PDF]
G. Guercio, M. A. Rivarola, E. Chaler, M. Maceiras, and A. Belgorosky Relationship between the Growth Hormone/Insulin-Like Growth Factor-I Axis, Insulin Sensitivity, and Adrenal Androgens in Normal Prepubertal and Pubertal Girls
J. Clin. Endocrinol. Metab.,
March 1, 2003;
88(3):
1389 - 1393.
[Abstract][Full Text][PDF]